Acadian Asset Management
CYTK icon

Acadian Asset Management’s Cytokinetics CYTK Stock Holding History

Acadian Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,541
Closed -$160K – 2068
2025
Q4 		$160K Buy
+2,541
New +$158K ﹤0.01% 1578
2024
Q4 		– Sell
-280
Closed -$14K – 1747
2024
Q3 		$14K Buy
+280
New +$15.6K ﹤0.01% 2016
2018
Q1 		– Sell
-84,158
Closed -$687K – 1700
2017
Q4 		$687K Sell
84,158
-314,919
-79% -$3.58M ﹤0.01% 761
2017
Q3 		$5.79M Sell
399,077
-367,186
-48% -$5.02M 0.03% 350
2017
Q2 		$9.27M Buy
766,263
+431,457
+129% +$6M 0.04% 291
2017
Q1 		$4.3M Buy
+334,806
New +$3.91M 0.02% 442
2016
Q3 		– Sell
-334,284
Closed -$3.17M – 1444
2016
Q2 		$3.17M Sell
334,284
-889,162
-73% -$7.3M 0.02% 452
2016
Q1 		$8.62M Buy
1,223,446
+53,134
+5% +$388K 0.04% 295
2015
Q4 		$12.2M Buy
1,170,312
+1,079,774
+1,193% +$10.6M 0.06% 267
2015
Q3 		$606K Sell
90,538
-40,276
-31% -$275K ﹤0.01% 754
2015
Q2 		$879K Buy
130,814
+103,813
+384% +$681K ﹤0.01% 703
2015
Q1 		$183K Buy
+27,001
New +$202K ﹤0.01% 934
2013
Q4 		– Sell
-1,118
Closed -$8K – 1052
2013
Q3 		$8K Buy
+1,118
New +$12K ﹤0.01% 945

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management's CYTK Position: Q1 2026 in Review

Acadian Asset Management sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 2,541 shares — an estimated $160K sold.

Acadian Asset Management first reported a position in CYTK in Q3 2013 and held it in 13 quarters. The position peaked at $12.2M in Q4 2015. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Acadian Asset Management reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 2,541 Cytokinetics shares in Q1 2026, an estimated $160K.
  • Acadian Asset Management first reported a position in Cytokinetics in Q3 2013 and held it in 13 quarters.
  • Acadian Asset Management's Cytokinetics position peaked at $12.2M in Q4 2015.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.